{"entity":{"type":"insider","cik":"0001817838","url":"/insider/0001817838","json_url":"/insider/0001817838.json","name":"Lyon Joseph Douglas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":36,"first":"2021-01-04","last":"2026-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Lyon Joseph Douglas","source":"filing","n_filings":36,"first_seen":"2021-01-04","last_seen":"2026-08-05"}],"transactions":[{"id":5837936,"accession":"0001193125-26-335605","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-335605","line_url":"/filing/0001193125-26-335605#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1540.0,"shares_display":"1,540","price_per_share":114.16,"price_display":"114.16","price_state":"stated","total_value":175806.4,"total_display":"175,806.40","total_whole":"175,806","shares_owned_after":5495.0,"shares_owned_after_display":"5,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-05","scope":"insider"},{"id":5944136,"accession":"0001193125-26-248977","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-248977","line_url":"/filing/0001193125-26-248977#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":325000.0,"total_display":"325,000.00","total_whole":"325,000","shares_owned_after":6230.0,"shares_owned_after_display":"6,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-27","filed_date":"2026-05-29","scope":"insider"},{"id":4456839,"accession":"0001193125-25-307229","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-307229","line_url":"/filing/0001193125-25-307229#line-4","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":79.5263,"price_display":"79.53","price_state":"stated","total_value":397631.5,"total_display":"397,631.50","total_whole":"397,632","shares_owned_after":10277.0,"shares_owned_after_display":"10,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-03","scope":"insider"},{"id":4940724,"accession":"0001193125-25-267548","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-267548","line_url":"/filing/0001193125-25-267548#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":73.6489,"price_display":"73.65","price_state":"stated","total_value":368244.5,"total_display":"368,244.50","total_whole":"368,245","shares_owned_after":10277.0,"shares_owned_after_display":"10,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-03","filed_date":"2025-11-05","scope":"insider"},{"id":4490831,"accession":"0001193125-25-230440","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-230440","line_url":"/filing/0001193125-25-230440","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":84.75315076,"price_display":"84.75","price_state":"stated","total_value":423765.7538,"total_display":"423,765.75","total_whole":"423,766","shares_owned_after":10877.0,"shares_owned_after_display":"10,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-03","scope":"insider","n_lines":3},{"id":4201792,"accession":"0001193125-25-196317","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-25-196317","line_url":"/filing/0001193125-25-196317","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":70.2494885,"price_display":"70.25","price_state":"stated","total_value":351247.4425,"total_display":"351,247.44","total_whole":"351,247","shares_owned_after":10171.0,"shares_owned_after_display":"10,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-04","scope":"insider","n_lines":2},{"id":4619862,"accession":"0000950170-25-103319","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-103319","line_url":"/filing/0000950170-25-103319#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5823.0,"shares_display":"5,823","price_per_share":67.5129,"price_display":"67.51","price_state":"stated","total_value":393127.6167,"total_display":"393,127.62","total_whole":"393,128","shares_owned_after":10066.0,"shares_owned_after_display":"10,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-01","filed_date":"2025-08-05","scope":"insider"},{"id":4101074,"accession":"0000950170-25-097371","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-097371","line_url":"/filing/0000950170-25-097371#line-4","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":73.4,"price_display":"73.40","price_state":"stated","total_value":14680.0,"total_display":"14,680.00","total_whole":"14,680","shares_owned_after":10066.0,"shares_owned_after_display":"10,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-18","filed_date":"2025-07-21","scope":"insider"},{"id":4101052,"accession":"0000950170-25-097371","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-097371","line_url":"/filing/0000950170-25-097371#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3877.0,"shares_display":"3,877","price_per_share":73.4753,"price_display":"73.48","price_state":"stated","total_value":284863.7381,"total_display":"284,863.74","total_whole":"284,864","shares_owned_after":10066.0,"shares_owned_after_display":"10,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-17","filed_date":"2025-07-21","scope":"insider"},{"id":4714671,"accession":"0000950170-25-094121","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-094121","line_url":"/filing/0000950170-25-094121#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":73.505,"price_display":"73.50","price_state":"stated","total_value":7350.5,"total_display":"7,350.50","total_whole":"7,351","shares_owned_after":10066.0,"shares_owned_after_display":"10,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-01","filed_date":"2025-07-03","scope":"insider"},{"id":4264420,"accession":"0000950170-25-081935","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-25-081935","line_url":"/filing/0000950170-25-081935","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":78.0436874,"price_display":"78.04","price_state":"stated","total_value":390218.437,"total_display":"390,218.44","total_whole":"390,218","shares_owned_after":9751.0,"shares_owned_after_display":"9,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-02","filed_date":"2025-06-04","scope":"insider","n_lines":2},{"id":4048387,"accession":"0000950170-25-063828","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-063828","line_url":"/filing/0000950170-25-063828#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9350.0,"shares_display":"9,350","price_per_share":71.9552,"price_display":"71.96","price_state":"stated","total_value":672781.12,"total_display":"672,781.12","total_whole":"672,781","shares_owned_after":9009.0,"shares_owned_after_display":"9,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-01","filed_date":"2025-05-05","scope":"insider"},{"id":4059714,"accession":"0000950170-25-049813","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000950170-25-049813","line_url":"/filing/0000950170-25-049813#line-9","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":650.0,"shares_display":"650","price_per_share":114.5277,"price_display":"114.53","price_state":"stated","total_value":74443.005,"total_display":"74,443.00","total_whole":"74,443","shares_owned_after":9009.0,"shares_owned_after_display":"9,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-02","scope":"insider"},{"id":4059709,"accession":"0000950170-25-049813","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950170-25-049813","line_url":"/filing/0000950170-25-049813","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":100.467552728,"price_display":"100.47","price_state":"stated","total_value":20093510.5456,"total_display":"20,093,510.55","total_whole":"20,093,511","shares_owned_after":47001.0,"shares_owned_after_display":"47,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-31","filed_date":"2025-04-02","scope":"insider","n_lines":3},{"id":4712961,"accession":"0000950170-25-045564","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-045564","line_url":"/filing/0000950170-25-045564#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":421.0,"shares_display":"421","price_per_share":60.58,"price_display":"60.58","price_state":"stated","total_value":25504.18,"total_display":"25,504.18","total_whole":"25,504","shares_owned_after":9009.0,"shares_owned_after_display":"9,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-24","filed_date":"2025-03-26","scope":"insider"},{"id":4980974,"accession":"0000950170-25-032755","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-25-032755","line_url":"/filing/0000950170-25-032755#line-5","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4579.0,"shares_display":"4,579","price_per_share":60.6905,"price_display":"60.69","price_state":"stated","total_value":277901.7995,"total_display":"277,901.80","total_whole":"277,902","shares_owned_after":9009.0,"shares_owned_after_display":"9,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":4047449,"accession":"0000950170-25-014454","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-014454","line_url":"/filing/0000950170-25-014454#line-3","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":66.92,"price_display":"66.92","price_state":"stated","total_value":334600.0,"total_display":"334,600.00","total_whole":"334,600","shares_owned_after":8759.0,"shares_owned_after_display":"8,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-05","scope":"insider"},{"id":4058941,"accession":"0000950170-25-002446","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-002446","line_url":"/filing/0000950170-25-002446#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":50.39,"price_display":"50.39","price_state":"stated","total_value":251950.0,"total_display":"251,950.00","total_whole":"251,950","shares_owned_after":8759.0,"shares_owned_after_display":"8,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-06","scope":"insider"},{"id":2125667,"accession":"0000950170-24-131170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-131170","line_url":"/filing/0000950170-24-131170#line-1","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1411.0,"shares_display":"1,411","price_per_share":56.72,"price_display":"56.72","price_state":"stated","total_value":80031.92,"total_display":"80,031.92","total_whole":"80,032","shares_owned_after":8494.0,"shares_owned_after_display":"8,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-22","filed_date":"2024-11-26","scope":"insider"},{"id":2771363,"accession":"0000950170-24-081631","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-081631","line_url":"/filing/0000950170-24-081631#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":32.4904,"price_display":"32.49","price_state":"stated","total_value":162452.0,"total_display":"162,452.00","total_whole":"162,452","shares_owned_after":9290.0,"shares_owned_after_display":"9,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider"},{"id":2082129,"accession":"0000950170-24-069608","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-069608","line_url":"/filing/0000950170-24-069608#line-5","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":30.1832,"price_display":"30.18","price_state":"stated","total_value":150916.0,"total_display":"150,916.00","total_whole":"150,916","shares_owned_after":7314.0,"shares_owned_after_display":"7,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-05","scope":"insider"},{"id":2588092,"accession":"0000950170-24-059035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-059035","line_url":"/filing/0000950170-24-059035#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7227.0,"shares_display":"7,227","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":187902.0,"total_display":"187,902.00","total_whole":"187,902","shares_owned_after":7314.0,"shares_owned_after_display":"7,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-09","filed_date":"2024-05-13","scope":"insider"},{"id":2275545,"accession":"0000950170-24-053847","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-053847","line_url":"/filing/0000950170-24-053847#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10830.0,"shares_display":"10,830","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":281580.0,"total_display":"281,580.00","total_whole":"281,580","shares_owned_after":7314.0,"shares_owned_after_display":"7,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-06","scope":"insider"},{"id":2081472,"accession":"0000950170-24-042725","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-042725","line_url":"/filing/0000950170-24-042725#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5443.0,"shares_display":"5,443","price_per_share":26.0011,"price_display":"26.00","price_state":"stated","total_value":141523.9873,"total_display":"141,523.99","total_whole":"141,524","shares_owned_after":7314.0,"shares_owned_after_display":"7,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-04","filed_date":"2024-04-08","scope":"insider"},{"id":3020114,"accession":"0000950170-24-041450","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-041450","line_url":"/filing/0000950170-24-041450#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":26.007,"price_display":"26.01","price_state":"stated","total_value":13003.5,"total_display":"13,003.50","total_whole":"13,004","shares_owned_after":7314.0,"shares_owned_after_display":"7,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":2634712,"accession":"0000950170-24-018325","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-018325","line_url":"/filing/0000950170-24-018325#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":26000.0,"total_display":"26,000.00","total_whole":"26,000","shares_owned_after":6774.0,"shares_owned_after_display":"6,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-21","scope":"insider"},{"id":8310956,"accession":"0000950170-23-068373","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-23-068373","line_url":"/filing/0000950170-23-068373#line-6","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2432.0,"shares_display":"2,432","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":63232.0,"total_display":"63,232.00","total_whole":"63,232","shares_owned_after":5854.0,"shares_owned_after_display":"5,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-05","scope":"insider"},{"id":8310952,"accession":"0000950170-23-068373","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-23-068373","line_url":"/filing/0000950170-23-068373#line-4","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2568.0,"shares_display":"2,568","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":66768.0,"total_display":"66,768.00","total_whole":"66,768","shares_owned_after":5854.0,"shares_owned_after_display":"5,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-01","filed_date":"2023-12-05","scope":"insider"},{"id":7838605,"accession":"0000950170-23-058943","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-23-058943","line_url":"/filing/0000950170-23-058943#line-4","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3977.0,"shares_display":"3,977","price_per_share":28.1102,"price_display":"28.11","price_state":"stated","total_value":111794.2654,"total_display":"111,794.27","total_whole":"111,794","shares_owned_after":5854.0,"shares_owned_after_display":"5,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-02","filed_date":"2023-11-03","scope":"insider"},{"id":7838599,"accession":"0000950170-23-058943","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-058943","line_url":"/filing/0000950170-23-058943#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1023.0,"shares_display":"1,023","price_per_share":28.08,"price_display":"28.08","price_state":"stated","total_value":28725.84,"total_display":"28,725.84","total_whole":"28,726","shares_owned_after":5854.0,"shares_owned_after_display":"5,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-01","filed_date":"2023-11-03","scope":"insider"},{"id":7919632,"accession":"0000950170-23-052700","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-052700","line_url":"/filing/0000950170-23-052700#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2582.0,"shares_display":"2,582","price_per_share":27.24,"price_display":"27.24","price_state":"stated","total_value":70333.68,"total_display":"70,333.68","total_whole":"70,334","shares_owned_after":5854.0,"shares_owned_after_display":"5,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-06","filed_date":"2023-10-10","scope":"insider"},{"id":8576565,"accession":"0000950170-23-051911","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-051911","line_url":"/filing/0000950170-23-051911#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2418.0,"shares_display":"2,418","price_per_share":27.2493,"price_display":"27.25","price_state":"stated","total_value":65888.8074,"total_display":"65,888.81","total_whole":"65,889","shares_owned_after":5854.0,"shares_owned_after_display":"5,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-04","scope":"insider"},{"id":8064938,"accession":"0000950170-23-046814","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-23-046814","line_url":"/filing/0000950170-23-046814#line-4","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":32.73,"price_display":"32.73","price_state":"stated","total_value":163650.0,"total_display":"163,650.00","total_whole":"163,650","shares_owned_after":5132.0,"shares_owned_after_display":"5,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-06","scope":"insider"},{"id":8400105,"accession":"0000950170-23-043973","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-23-043973","line_url":"/filing/0000950170-23-043973#line-3","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4588.0,"shares_display":"4,588","price_per_share":31.19,"price_display":"31.19","price_state":"stated","total_value":143099.72,"total_display":"143,099.72","total_whole":"143,100","shares_owned_after":5132.0,"shares_owned_after_display":"5,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-22","scope":"insider"},{"id":8108433,"accession":"0000950170-23-040748","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-040748","line_url":"/filing/0000950170-23-040748#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":412.0,"shares_display":"412","price_per_share":31.22,"price_display":"31.22","price_state":"stated","total_value":12862.64,"total_display":"12,862.64","total_whole":"12,863","shares_owned_after":4720.0,"shares_owned_after_display":"4,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-07","filed_date":"2023-08-09","scope":"insider"},{"id":8186285,"accession":"0000899243-23-014751","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-014751","line_url":"/filing/0000899243-23-014751#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":23.6,"price_display":"23.60","price_state":"stated","total_value":236000.0,"total_display":"236,000.00","total_whole":"236,000","shares_owned_after":5132.0,"shares_owned_after_display":"5,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-07","scope":"insider"},{"id":4867380,"accession":"0000899243-21-014861","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-014861","line_url":"/filing/0000899243-21-014861#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":23.8812,"price_display":"23.88","price_state":"stated","total_value":597030.0,"total_display":"597,030.00","total_whole":"597,030","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-05","scope":"insider"},{"id":4867130,"accession":"0000899243-21-009450","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-009450","line_url":"/filing/0000899243-21-009450#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":25.2128,"price_display":"25.21","price_state":"stated","total_value":630320.0,"total_display":"630,320.00","total_whole":"630,320","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":5275519,"accession":"0000899243-21-004968","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-004968","line_url":"/filing/0000899243-21-004968#line-2","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":29.1828,"price_display":"29.18","price_state":"stated","total_value":729570.0,"total_display":"729,570.00","total_whole":"729,570","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2021-02-04","scope":"insider"},{"id":5363015,"accession":"0000899243-21-000214","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-21-000214","line_url":"/filing/0000899243-21-000214#line-5","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":26.1338,"price_display":"26.13","price_state":"stated","total_value":653345.0,"total_display":"653,345.00","total_whole":"653,345","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-04","scope":"insider"},{"id":5363010,"accession":"0000899243-21-000214","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-000214","line_url":"/filing/0000899243-21-000214#line-3","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":"0001817838","owner_name":"Lyon Joseph Douglas","owner_display_name":"Lyon Joseph Douglas","owner_url":"/insider/0001817838","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":26.0701,"price_display":"26.07","price_state":"stated","total_value":651752.5,"total_display":"651,752.50","total_whole":"651,753","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-30","filed_date":"2021-01-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":47,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":47},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001088856","name":"CORCEPT THERAPEUTICS INC","url":"/issuer/0001088856","role":"Officer","n_filings":36,"first_seen":"2021-01-04","last_seen":"2026-08-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001817838","retrieved_at":"2026-08-24T10:00:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}